Orca-T Offers an Alternative to HSCT With Improved Patient Experience – OncLive

Advances in the treatment of patients with leukemias and lymphomas have led to a significant improvement in survival, which has increased the need for bone marrow transplant as a later-line therapy, said Mehrdad Abedi, MD, who added that Orca-T, a high precision cell therapy, confers significant antitumor activity, minimizes the incidence of acute and chronic graft-vs-host disease (GVHD), and causes less adverse effects (AEs) compared with standard bone marrow transplant among these patients. There is a lot of research [ongoing]; the holy grail of research is trying to figure out whether we can separate the graft-vs-leukemia or graft-vs-lymphoma effect from GVHD, said Abedi.

Read more
Global Automated and Closed Cell Therapy Processing Systems Market Trends and Forecasts, 2020-2030: Cell Processing Steps, Scale of Operations, End…

Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Automated and Closed Cell Therapy Processing Systems Market By Cell Processing Steps, Scale of Operations, End Users and Geographical Regions: Industry Trends and Global Forecasts, 2020 - 2030" report has been added to ResearchAndMarkets.com's offering. The "Automated and Closed Cell Therapy Processing Systems Market: Focus on Apheresis, Expansion, Harvest, Fill/Finish, Cryopreservation, Thawing, 2020-2030" report features an extensive study of the current market landscape and future opportunities associated with the automated and closed cell therapy processing systems. The study also features a detailed analysis of key drivers and trends related to this evolving domain

Read more
Cultured Meat: What to Know – WebMD

In this Article In this Article In this Article Cultured meat, sometimes called lab-grown, clean, or cultivated meat, is grown in a lab from a few animal cells. It's real meat, but it doesn't require animals to be slaughtered the way traditional meat does. The idea is to create a more ecologically friendly and humane meat industry

Read more
Hydrogel used to revert cancer cells back to cancer stem cells – Drug Target Review

A new hydrogel has been shown to convert cancer cells to cancer stem cells within 24 hours, in six different human cancer cell line types. A hydrogel developed at Hokkaido University, Japan, successfully reverted cancer cells back to cancer stem cells within 24 hours, in six different human cancer types. According to the researchers, this could lead to the development of anticancer stem cell drugs and personalised medicines.

Read more
Phase 3 Trial of Stem Cell Therapy NeuroNata-R Likely to Expand to US – ALS News Today

A Phase 3 clinical trial is recruiting adults with amyotrophic lateral sclerosis(ALS) to evaluate the safety and effectiveness of NeuroNata-R (lenzumestrocel), a stem cell therapy approved to treat ALS in South Korea. Enrollment is currently ongoing in South Korea, with additional sites expected to open in the U.S.,Corestem, the therapys developer, stated in an email to ALS News Today. With U.S.

Read more